News

Fierce Biotech29m
Biohaven, after setbacks, sees shares jump with Oberland Capital funding agreement worth up to $600M
Oberland Capital Management is pumping some new life into Biohaven, striking a unique investment deal worth up to $600 ...
The Manila Times29m
Voyager Next-Generation CNS Capsids Featured at ASGCT 28th Annual Meeting
Cross-species BBB-penetrant IV-delivered AAV gene therapy provides broad and robust CNS tau lowering in tauopathy mouse ...